Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mithramycin therapy in Paget's disease.

A S Russell, B C Lentle

    Canadian Medical Association Journal
    |February 16, 1974
    PubMed
    Summary
    This summary is machine-generated.

    Mithramycin effectively treated symptomatic Paget's disease in nine patients, significantly improving symptoms and reducing key biochemical markers. The treatment demonstrated safety and efficacy for this bone disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Osteoporotic vertebral fracture (OVF): diagnosis requires an informed observer.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
    Same author

    The diagnosis of osteoporotic vertebral fractures redux.

    Clinical radiology·2021
    Same author

    Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
    Same author

    Correction to: PANLAR consensus statement on biosimilars.

    Clinical rheumatology·2019
    Same author

    PANLAR consensus statement on biosimilars.

    Clinical rheumatology·2019
    Same author

    Hot joints: myth or reality? A thermographic joint assessment of inflammatory arthritis patients.

    Clinical rheumatology·2018

    Area of Science:

    • Endocrinology
    • Oncology
    • Rheumatology

    Background:

    • Paget's disease of bone is a chronic condition characterized by abnormal bone remodeling.
    • Symptomatic Paget's disease often requires effective therapeutic interventions.

    Purpose of the Study:

    • To evaluate the efficacy and safety of mithramycin in treating symptomatic Paget's disease.
    • To assess the impact of mithramycin on clinical symptoms and biochemical markers of Paget's disease.

    Main Methods:

    • Nine patients with symptomatic Paget's disease received mithramycin at 15 mug/kg/day for 10 days.
    • Clinical symptoms, serum alkaline phosphatase, and urinary hydroxyproline excretion were monitored.
    • Bone scans using technetium-99m stannous polyphosphate were performed in six patients.

    Related Experiment Videos

    Main Results:

    • Eight out of nine patients experienced considerable symptomatic improvement, with some reporting dramatic pain relief.
    • A progressive decrease in serum alkaline phosphatase and urinary hydroxyproline excretion was observed.
    • Bone scans showed improvement in five patients during therapy, with continued improvement post-treatment in some cases.

    Conclusions:

    • Mithramycin is an effective therapeutic agent for symptomatic Paget's disease.
    • The studied dose of mithramycin demonstrated a favorable safety profile.
    • Mithramycin offers a viable treatment option for patients suffering from Paget's disease.